HR5801-118

1. Short title This Act may be cited as the Preventing Overdoses with Test Strips Act.

2. Amending the 21st Century Cures Act to authorize the use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances Section 1003 of the 21st Century Cures Act (42 U.S.C. 290ee–3a) is amended— in subsection (b)(4), by adding at the end the following: Providing assistance for expenses relating to the acquisition or use of adulterant substance detection devices. in subsection (h)— by redesignating paragraphs (1) through (4) as paragraphs (2) through (5), respectively; and by inserting before paragraph (2) (as so redesignated), the following: The term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance. (G)Providing assistance for expenses relating to the acquisition or use of adulterant substance detection devices. ; and (1)Adulterant substance detection deviceThe term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance..

3. Amending the Public Health Service Act to authorize the use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances Part A of title V of the Public Health Service Act (42 U.S.C. 290aa et seq.) is amended by adding at the end the following: Expenses relating to the acquisition or use of adulterant substance detection devices shall be allowable expenses under any grant, contract, or cooperative agreement entered into by the Substance Abuse and Mental Health Services Administration under this Act. In this section, the term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance. 506B.Use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances(a)In generalExpenses relating to the acquisition or use of adulterant substance detection devices shall be allowable expenses under any grant, contract, or cooperative agreement entered into by the Substance Abuse and Mental Health Services Administration under this Act.(b)DefinitionIn this section, the term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance. .

506B. Use of funds for devices for use in the detection of fentanyl, xylazine, and other emerging adulterant substances Expenses relating to the acquisition or use of adulterant substance detection devices shall be allowable expenses under any grant, contract, or cooperative agreement entered into by the Substance Abuse and Mental Health Services Administration under this Act. In this section, the term adulterant substance detection device means a device, including a test strip, that can detect the presence of an adulterant, such as fentanyl, xylazine, or another adulterant in a drug sample prior to use of a controlled substance.